New Parkinson's drug candidate tested in small chinese trial

NCT ID NCT07513441

Not yet recruiting Symptom relief Sponsor: H. Lundbeck A/S Source: ClinicalTrials.gov ↗

First seen Apr 14, 2026 · Last updated May 22, 2026 · Updated 7 times

Summary

This early-stage study tests a new drug called Lu AF28996 in 10 Chinese adults with Parkinson's disease. The main goal is to check the drug's safety and how the body processes it. Participants must have moderate Parkinson's with predictable movement fluctuations. This trial does not aim to cure the disease but to see if the drug can be safely used to ease symptoms.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Beijing Tiantan Hospital, Capital Medical University

Beijing, 100070, China
Huashan Hospital, Fudan University

Shanghai, 200040, China
West China Hospital, Sichuan University

Chengdu, 610041, China
Xuanwu Hospital Capital Medical University

Beijing, 100053, China

Conditions

Explore the condition pages connected to this study.

PARKINSON DISEASE